These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12574430)

  • 1. Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion.
    Narita M; Mizuo K; Mizoguchi H; Sakata M; Narita M; Tseng LF; Suzuki T
    J Neurosci; 2003 Feb; 23(3):1006-12. PubMed ID: 12574430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.
    Ozaki S; Narita M; Narita M; Iino M; Sugita J; Matsumura Y; Suzuki T
    J Neurochem; 2002 Sep; 82(5):1192-8. PubMed ID: 12358766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
    Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
    Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced morphine withdrawal and micro -opioid receptor G-protein coupling in A2A adenosine receptor knockout mice.
    Bailey A; Davis L; Lesscher HM; Kelly MD; Ledent C; Hourani SM; Kitchen I
    J Neurochem; 2004 Feb; 88(4):827-34. PubMed ID: 14756803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu opioid receptor signaling in morphine sensitization.
    Viganò D; Rubino T; Di Chiara G; Ascari I; Massi P; Parolaro D
    Neuroscience; 2003; 117(4):921-9. PubMed ID: 12654343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
    J Pharmacol Exp Ther; 1996 Oct; 279(1):177-85. PubMed ID: 8858991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.
    Narita M; Nagumo Y; Hashimoto S; Narita M; Khotib J; Miyatake M; Sakurai T; Yanagisawa M; Nakamachi T; Shioda S; Suzuki T
    J Neurosci; 2006 Jan; 26(2):398-405. PubMed ID: 16407535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
    Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF
    Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice.
    Mizoguchi H; Narita M; Oji DE; Suganuma C; Nagase H; Sora I; Uhl GR; Cheng EY; Tseng LF
    Neuroscience; 1999; 94(1):203-7. PubMed ID: 10613510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state.
    Niikura K; Narita M; Narita M; Nakamura A; Okutsu D; Ozeki A; Kurahashi K; Kobayashi Y; Suzuki M; Suzuki T
    Neurosci Lett; 2008 Apr; 435(3):257-62. PubMed ID: 18359165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
    Gray RE; Munks MW; Haynes RR; Olsen GD
    Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice.
    Funada M; Suzuki T; Narita M; Misawa M; Nagase H
    Brain Res; 1993 Aug; 619(1-2):163-72. PubMed ID: 8374774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
    Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
    Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice.
    Bohn LM; Gainetdinov RR; Sotnikova TD; Medvedev IO; Lefkowitz RJ; Dykstra LA; Caron MG
    J Neurosci; 2003 Nov; 23(32):10265-73. PubMed ID: 14614085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice.
    Mizuo K; Narita M; Miyagawa K; Narita M; Okuno E; Suzuki T
    Neurosci Lett; 2004 Feb; 356(2):95-8. PubMed ID: 14746872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain.
    Selley DE; Herbert JT; Morgan D; Cook CD; Picker MJ; Sim-Selley LJ
    Brain Res Bull; 2003 May; 60(3):201-8. PubMed ID: 12754081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.